Nuvo Reseach NRI.to FDA decision Pliaglis

FDA decision on Pliaglis are reporter today because they don't have any information on the product. It's not a bad news same if the stock price have down today. This news just want say that the answer of the FDA will be reported. Nuvo research should,against me, give the reason on their web site because the investor don't no what will be appened. As soon as the FDA will receive all the information, FDA will give the decision if Pliaglis will be approuved. More detail to come.